Natassia Tan

ORCID: 0000-0002-0967-3282
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Gallbladder and Bile Duct Disorders
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gastrointestinal disorders and treatments
  • Lipoproteins and Cardiovascular Health
  • Folate and B Vitamins Research
  • Multiple and Secondary Primary Cancers
  • Potassium and Related Disorders
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Inflammatory Bowel Disease
  • Helicobacter pylori-related gastroenterology studies
  • Esophageal and GI Pathology
  • Genetic factors in colorectal cancer
  • Electrolyte and hormonal disorders
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Cancer, Lipids, and Metabolism
  • Gastroesophageal reflux and treatments
  • Aluminum toxicity and tolerance in plants and animals
  • Eicosanoids and Hypertension Pharmacology
  • Diverticular Disease and Complications
  • Digestive system and related health
  • Inflammatory mediators and NSAID effects

The Alfred Hospital
2022-2025

Monash University
2023-2025

Eastern Health
2019-2025

Alfred Health
2023-2024

Vietnam Sweden hospital
1998

ABSTRACT Background and Aims Primary sclerosing cholangitis (PSC) is a rare, cholestatic liver condition that has significant association with inflammatory bowel disease (IBD) impaired health‐related quality of life (HRQOL). We aimed to characterise compare validated PSC IBD patient‐reported outcomes (PRO) determine if PRO correlated the severity disease. Methods conducted multicentre, prospective cohort study in Australia enrolling adult patients from December 2019 August 2023. Consecutive...

10.1111/apt.70054 article EN cc-by-nc Alimentary Pharmacology & Therapeutics 2025-03-02

Background: The benefits of regular surveillance imaging for cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC) are unclear. Hence, we aimed to evaluate the impact magnetic resonance cholangiopancreatography (MRCP) on outcomes PSC Australia, where practice MRCP is variable. Methods: relationship between and survival was assessed a multicenter, retrospective cohort from 9 tertiary liver centers Australia. An inverse probability treatment weighting approach used balance...

10.1097/hc9.0000000000000442 article EN cc-by-nc-nd Hepatology Communications 2024-05-01

Abstract Background and aims Little is known regarding the epidemiology outcomes of patients with primary sclerosing cholangitis (PSC) in Australia. We, therefore, evaluated clinical PSC a large cohort Australian compared these to general population. Methods We conducted multicentre, retrospective study at nine tertiary liver centers across three states, including two transplant centers. Results A total 413 3,285 person-years follow-up were included. Three hundred seventy-one (90%) had duct...

10.1007/s12072-022-10356-1 article EN cc-by Hepatology International 2022-06-03

Abstract Background Alanine aminotransferase (ALT) and aspartate (AST) are commonly ordered tests in general medical practice. However, their distribution significance older adults understudied. As such, we aimed to evaluate sex-stratified of both ALT AST (≥70 years) assess for associations with mortality. Methods Post-hoc analysis the ASPirin Reducing Events Elderly (ASPREE) randomized, placebo-controlled trial daily low-dose aspirin initially relatively healthy persons. Univariate multiple...

10.1093/gerona/glae203 article EN cc-by-nc The Journals of Gerontology Series A 2024-08-17
Coming Soon ...